Advertisement
Singapore markets closed

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,069.79
    -0.76 (-0.01%)
     

  • Dow

    38,433.53
    -70.16 (-0.18%)
     

  • Nasdaq

    15,759.43
    +62.79 (+0.40%)
     

  • Bitcoin USD

    65,007.94
    -1,719.78 (-2.58%)
     

  • CMC Crypto 200

    1,412.35
    -11.75 (-0.83%)
     

  • FTSE 100

    8,049.92
    +5.11 (+0.06%)
     

  • Gold

    2,339.50
    -2.60 (-0.11%)
     

  • Crude Oil

    83.48
    +0.12 (+0.14%)
     

  • 10-Yr Bond

    4.6670
    +0.0690 (+1.50%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Will Pretium Resources Continue to Surge Higher?

Zacks Equity Research

As of late, it has definitely been a great time to be an investor Pretium Resources Inc. PVG.The stock has moved higher by 34.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider PVG’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as PVG has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

ADVERTISEMENT

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pretium Resources, Inc. (PVG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research